MW: 147,075.91 Da
No. of AA: 1278
Abs 0.1% (g/L): 1.315
pI: 5.59
NCBI ID: WP_011987710.1
UniprotKB: A7GBG3
Strains: 12F, 4VI, 8g, FT 14, Langeland, Walls 8G, Pasteurized Crab, FT 15, NCTC 10281, 4VII, FT 42-2, 5052, 230613, Walls 8G (2), Walls 8G (4), Langeland (2), Walls 8G (3), IFR 18/146, KM87-1-86F, KM90-1-8G-F, KM88-1-PC-F
Associated Proteins:
Notes:
Sequence diversity of genes encoding botulinum neurotoxin type F.
Raphael BH, Choudoir MJ, Luquez C, Fernandez R, Maslanka SE. (2010). Appl Environ Microbiol.
DOI: 10.1128/AEM.03109-09 PMID: 20511432
Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
Agarwal R, Schmidt JJ, Stafford RG, Swaminathan S. (2009). Nat. Struct. Mol. Biol.
DOI: 10.1038/nsmb.1626 PMID: 19543288
Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
Agarwal R, Binz T, Swaminathan S. (2005). Biochemistry
DOI: PMID: 16128577
Comparative characterization of botulinum neurotoxin subtypes F1 and F7 featuring differential substrate recognition and cleavage mechanisms.
Guo J, Chan EW, Chen S. (2015). Toxicon
DOI: 10.1016/j.toxicon.2015.12.020 PMID: 26748154
Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.
Joussain C, Le Coz O, Pichugin A, Marconi P, Lim F, Sicurella M, Salonia A, Montorsi F, Wandosell F, Foster K, Giuliano F, Epstein AL, Aranda Muñoz A. (2019). Toxins (Basel)
DOI: 10.3390/toxins11020123 PMID: 30791373